Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hypophosphatasia (HPP) and Osteogenesis Imperfecta (OI) Genetic Panel (2 Day STAT TAT) Machaon Diagnostics United States | 18 | 15 |
|
Health in Code Spain | 71 | 35 |
|
Aortic Valvular Diseases Panel Health in Code Spain | 60 | 30 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
COL1A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 7 | 1 |
|
COL1A2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 7 | 1 |
|
Invitae Connective Tissue Disorders Panel Invitae United States | 195 | 92 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 345 | 159 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Bone Fragility and Fracture Panel PreventionGenetics, part of Exact Sciences United States | 87 | 74 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 110 | 50 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Osteogenesis imperfecta, type IV, 166220, Autosomal Dominant (Osteogenesis imperfecta) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Osteogenesis imperfecta, type IV, 166220, Autosomal dominant; OI4 (Osteogenesis imperfecta) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Connective Tissue Disorders Panel PreventionGenetics, part of Exact Sciences United States | 166 | 101 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.